Table 3. Methylation index (MI) in hereditary and sporadic CRC tumors.
Low MI | High MI | |
---|---|---|
MSS HNPCC | 100% (22) | 0% (0) |
Lynch syndrome | 90.5% (19) | 9.5% (2) |
MSI sporadic | 32.6% (15) | 67.4% (31) |
MSS sporadic | 95.6% (87) | 4.4% (4) |
Low MI | High MI | |
---|---|---|
MSS HNPCC | 100% (22) | 0% (0) |
Lynch syndrome | 90.5% (19) | 9.5% (2) |
MSI sporadic | 32.6% (15) | 67.4% (31) |
MSS sporadic | 95.6% (87) | 4.4% (4) |